[蛋白质诱导的接近性和新降解剂的向降解:概念,发展,临床应用的挑战]
1Sorbonne Université, Institut de Biologie Paris Seine (IBPS), CNRS UMR 8256, Inserm ERL U1164, 7 quai Saint-Bernard, 75252 Paris, France.
Biologie aujourd'hui
|July 15, 2024
概括
有针对性的蛋白质降解,包括PROTACs和分子,为各种疾病提供了新的治疗策略. 较新的溶解体降解剂在治疗神经退行性疾病等疾病方面表现有前途.
科学领域:
- 药物发现 药物发现
- 生物化学 生化学
- 分子生物学分子生物学
背景情况:
- 向蛋白质降解是药物发现领域快速发展的一个领域.
- 它提供了新的方法来向以前被认为是不可抗药的蛋白质.
- 现在的策略超越了蛋白质,扩展到聚合物,有机体和核酸.
研究的目的:
- 审查针对药物发现的向蛋白质降解策略的最新进展.
- 要突出蛋白质和 lysosomal 降解剂的机制和应用.
- 讨论这些新型治疗方法在各种人类疾病中的潜力.
主要方法:
- 对针对性蛋白质降解的最新文献的综述.
- 降解剂的分类基于它们的机制 (蛋白质体与 lysosomal).
- 讨论各种PROTAC衍生物和溶酶体降解系统 (LYTACs,ATTEC,AUTAC,AUTOTAC) 的讨论.
主要成果:
- 普罗塔克和分子粘剂利用了全方位蛋白酶体系统.
- 溶酶体降解剂 (LYTACs,ATTEC,AUTAC,AUTOTAC) 向细胞外/膜蛋白和细胞器.
- 溶酶体降解剂克服了蛋白质体系统的局限性,显示了神经退行性疾病的潜力.
结论:
- 有针对性的蛋白质降解策略正在导致各种人类疾病的潜在药物.
- 制药公司正在积极开发这些治疗癌症,炎症和神经退行症的疗法.
- 该评论讨论了与这些新型治疗方法相关的效率和风险.
关键词:
自杀法 自杀法 自杀法 自杀法自自是自的过程.降解剂 降解剂是一种降解剂.药物 药物 药物 药物 药物 药物蛋白质和器官的有针对性的降解.dégradeurs dégradeurs dégradeurs dégradeurs dégradeurs dégradeurs dégradeurs dégradeurs dégradeurs dégradeurs dégradeurs dégradeurs dégradeurs dégradeurs dégradeurs dégradeurs dégradeurs dégradeurs dégradeurs dégradeurs dégradeurs dégradeurs这些药物是药物.蛋白质酶体蛋白质组是什么保护了一些人.有针对性的蛋白质和有机细胞降解.相关概念视频
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
The Proteasome
827
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
827
Role of Matrix Metalloproteases in Degradation of ECM
2.4K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.4K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
GPCR Desensitization
5.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.9K
Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K


